Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cobe Labs

This article was originally published in The Gray Sheet

Executive Summary

Gambro unit receives FDA clearance for the Trima automated blood component collection system, the firm reports Feb. 11. An alternative to whole blood collections, the system is the "first device to allow blood centers to collect combinations of red blood cells, platelets, and plasma simultaneously from a single blood donor," the company says. By collecting the blood products from the same donor, the Trima system yields "more transfusable products per donation than conventional whole blood collection"
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT011320

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel